← FDA Drug Approvals (Drugs@FDA)
CEFEPIME HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASTRAL · Approved 2020-07-21
Drug application
- FDA Application #
ANDA212721- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CEFEPIME HYDROCHLORIDE
- Generic name
- Cefepime Hydrochloride
- Active ingredients
- CEFEPIME HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- ASTRAL
- First approval
- 2020-07-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown